In a 16 year follow-up of the European Randomized Study of Screening for Prostate Cancer (ERSPC), the unnecessary biopsy was 76% (i.e., 76% of elevated PSA cases have a negative biopsy) [10]. The gene discussed is KLK3; the disease is prostate cancer.